Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
49.36 USD | +0.45% | +2.39% | -3.69% |
11:29am | Novartis Nominates Former Bristol Myers Squibb CEO as New Chair | MT |
11:12am | Novartis Lifts 2024 Guidance as First-quarter Earnings Grow on Strong Blockbuster Drug Demand | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-3.69% | 99.59B | |
+27.25% | 659B | |
+27.68% | 557B | |
-4.60% | 359B | |
+16.66% | 322B | |
+9.63% | 297B | |
+5.92% | 215B | |
+4.93% | 210B | |
-6.01% | 200B | |
-8.35% | 149B |
- Stock Market
- Equities
- BMY Stock
- News Bristol-Myers Squibb Company
- Bristol Myers Squibb : Secures European Approval for Onureg in Acute Myeloid Leukemia